Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?
Syed Mohammad Tariq,1 Enson C Thomas2 1Department of Respiratory Medicine, Luton and Dunstable University Hospital, Luton, 2Respiratory Unit, Bedford Hospital, Bedford, UK Abstract: Long-term maintenance therapy for COPD is evolving rapidly. Dual bronchodilation with new long-acting muscarinic ant...
Main Authors: | Tariq SM, Thomas EC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-06-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/maintenance-therapy-in-copd-time-to-phase-out-ics-and-switch---to-the--peer-reviewed-article-COPD |
Similar Items
-
Management of chronic obstructive pulmonary disease: Insights into patient profile – Use of inhaled corticosteroids/long-acting β2-Agonists or long-acting β2-agonists/long-acting muscarinic antagonists
by: Nevin Kishore, et al.
Published: (2020-01-01) -
When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment
by: Cheng WC, et al.
Published: (2020-12-01) -
Impact and prevention of severe exacerbations of COPD: a review of the evidence
by: Halpin DMG, et al.
Published: (2017-10-01) -
Critical Error Frequency and the Impact of Training with Inhalers Commonly used for Maintenance Treatment in Chronic Obstructive Pulmonary Disease
by: Collier DJ, et al.
Published: (2020-06-01) -
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy
by: Mapel D, et al.
Published: (2017-06-01)